Adriana Rodrigues Fonseca

Adriana Rodrigues Fonseca

Auto-generated profile, based on publicly available information

Adriana Rodrigues Fonseca

Department of Pediatric Rheumatology, Instituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro Rio de Janeiro Brazil

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2014 in Rheumatology
Verified
Journal Article
Open access
PDF file
AFAdriana R. Fonseca
Adriana R. Fonseca
MGMaria Ignez C. Gaspar-Elsas
Maria Ignez C. Gaspar-Elsas
Marcelo Gerardin Poirot LandMarcelo Gerardin Poirot Land
Marcelo Gerardin Poirot Land
SOSheila K. F. de Oliveira
Sheila K. F. de Oliveira
Objective. The most widely used classification criteria for SLE are those derived and validated in adult patients by the ACR. Alternatives include the Boston weighted (BW) and SLICC criteria. The aim of this study was to compare the performance of BW and SLICC criteria with the 1997 ACR criteria in a JSLE cohort. Methods. Cases were JSLE patients and controls were patients with other rheumatic diseases attending a tertiary centre in the past 10 years. Data were retrospectively collected to establish the ACR, BW and SLICC criteria fulfilled at the first visit and within the first year of follow-up. A consensus diagnosis of JSLE established by the same group of highly experienced paediatric rheumatologists was chosen as the standard of reference. Results. One hundred and seventy-three patients were included: 81 JSLE and 92 controls. There was a sharp increase in sensitivity and prevalence of all criteria within the first year of follow-up. The BW criteria had higher sensitivity than the ACR criteria (81.5% vs 58%, P < 0.001) at the first visit, but lower specificity in both periods. SLICC criteria had higher sensitivity (82.7% vs 58%, P < 0.001) at the first visit, but similar specificity in both periods. Conclusion. In this JSLE population, the SLICC criteria performed best in terms of sensitivity and accuracy at the first visit and within the first year of follow-up.

15 May 2019 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
AFAdriana Rodrigues Fonseca
Adriana Rodrigues Fonseca
MRMarta Cristine Felix Rodrigues
Marta Cristine Felix Rodrigues
FSFlavio Roberto Sztajnbok
Flavio Roberto Sztajnbok
Marcelo Gerardin Poirot LandMarcelo Gerardin Poirot Land
Marcelo Gerardin Poirot Land
SOSheila Knupp Feitosa de Oliveira
Sheila Knupp Feitosa de Oliveira
To date there are no specific classification criteria for childhood-onset systemic lupus erythematosus (cSLE). This study aims to compare the performance among the American College of Rheumatology (ACR) 1997, the Systemic Lupus International Collaborating Clinics criteria (SLICC) and the new European League Against Rheumatism (EULAR)/ACR criteria, in a cSLE cohort. We conducted a medical chart review study of cSLE cases and controls with defined rheumatic diseases, both ANA positive, to establish each ACR1997, SLICC and EULAR/ACR criterion fulfilled, at first visit and 1-year-follow-up. Study population included 122 cSLE cases and 89 controls. At first visit, SLICC criteria had higher sensitivity than ACR 1997 (89.3% versus 70.5%, p < 0.001), but similar specificity (80.9% versus 83.2%, p = 0.791), however performance was not statistically different at 1-year-follow-up. SLICC better scored in specificity compared to EULAR/ACR score ≥ 10 at first visit (80.9% versus 67.4%, p = 0.008) and at 1-year (76.4% versus 58.4%, p = 0.001), although sensitivities were similar. EULAR/ACR criteria score ≥ 10 exhibited higher sensitivity than ACR 1997 (87.7% versus 70.5%, p < 0.001) at first visit, but comparable at 1-year, whereas specificity was lower at first visit (67.4% versus 83.2%, p = 0.004) and 1-year (58.4% versus 76.4%, p = 0.002). A EULAR/ACR score ≥ 13 against a score ≥ 10, resulted in higher specificity, positive predictive value, and cut-off point accuracy. Compared to SLICC, a EULAR/ACR score ≥ 13 resulted in lower sensitivity at first visit (76.2% versus 89.3%, p < 0.001) and 1-year (91% versus 97.5%, p = 0.008), but similar specificities at both assessments. When compared to ACR 1997, a EULAR/ACR total score ≥ 13, resulted in no differences in sensitivity and specificity at both observation periods. In this cSLE population, SLICC criteria better scored at first visit and 1-year-follow-up. The adoption of a EULAR/ACR total score ≥ 13 in this study, against the initially proposed ≥10 score, was most appropriate to classify cSLE. Further studies are necessary to address if SLICC criteria might allow fulfillment of cSLE classification earlier in disease course and may be more inclusive of cSLE subjects for clinical studies.

4 August 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
JPJonas Johannes Papendorf
Jonas Johannes Papendorf
FEFrédéric Ebstein
Frédéric Ebstein
SASara Alehashemi
Sara Alehashemi
DPDaniela Gerent Petry Piotto
Daniela Gerent Petry Piotto
AKAnna Kozlova
Anna Kozlova
EKElke Krüger
Elke Krüger
Mutations in genes coding for proteasome subunits and/or proteasome assembly helpers typically cause recurring autoinflammation referred to as chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures (CANDLE) or proteasome-associated autoinflammatory syndrome (PRAAS). Patients with CANDLE/PRAAS present with mostly chronically elevated type I interferon scores that emerge as a consequence of increased proteotoxic stress by mechanisms that are not fully understood. Here, we report on five unrelated patients with CANDLE/PRAAS carrying novel inherited proteasome missense and/or nonsense variants. Four patients were compound heterozygous for novel pathogenic variants in the known CANDLE/PRAAS associated genes, PSMB8 and PSMB10, whereas one patient showed additive loss-of-function mutations in PSMB8. Variants in two previously not associated proteasome genes, PSMA5 and PSMC5, were found in a patient who also carried the PSMB8 founder mutation, p.T75M. All newly identified mutations substantially impact the steady-state expression of the affected proteasome subunits and/or their incorporation into mature 26S proteasomes. Our observations expand the spectrum of PRAAS-associated genetic variants and improve a molecular diagnosis and genetic counseling of patients with sterile autoinflammation.

4 January 2022 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
NCNathalie E. Chalhoub
Nathalie E. Chalhoub
SWScott E. Wenderfer
Scott E. Wenderfer
DLDeborah M. Levy
Deborah M. Levy
KRKelly Rouster‐Stevens
Kelly Rouster‐Stevens
AAAmita Aggarwal
Amita Aggarwal
FPfor the Childhood Arthritis and Rheumatology Research Alliance Lupus Nephritis Work Group and the Pediatric Rheumatology European Society Lupus Working Party
for the Childhood Arthritis and Rheumatology Research Alliance Lupus Nephritis Work Group and the Pediatric Rheumatology European Society Lupus Working Party

1 January 2012 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
AFAdriana R. Fonseca
Adriana R. Fonseca
SOSheila K. F. de Oliveira
Sheila K. F. de Oliveira
MRMarta C. F. Rodrigues
Marta C. F. Rodrigues
IAIerecê L. Aymoré
Ierecê L. Aymoré
RDRomeu C. Domingues
Romeu C. Domingues
FSFlavio R. Sztajnbok
Flavio R. Sztajnbok

13 June 2019 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
BGBrazilian Childhood-onset Systemic Lupus Erythematosus Group
Brazilian Childhood-onset Systemic Lupus Erythematosus Group
FFFernanda J. Fiorot
Fernanda J. Fiorot
AIAline G. Islabão
Aline G. Islabão
RPRosa Maria L.N. Pereira
Rosa Maria L.N. Pereira
MTMaria T. Terreri
Maria T. Terreri
CSClovis A. Silva
Clovis A. Silva